Sero-prevalence of herpes simplex virus type 2 (HSV-2) in Rakai District, Uganda

East African Medical Journal

Volumn 77, Issue 8, 2000, Pages 428-430

  Emonyi, I W ^a   Gray, R H ^a,f   Zenilman, J ^b   Schmidt, K ^a   Wawer, M J ^c   Sewankambo, K N ^g   Serwadda, D ^d   Kiwanuka, N ^e   Nalugoda, F ^e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Columbia Unviersity Sch of Pub H ^*  (United States)

^d MAKERERE UNIVERSITY   (Uganda)

^e UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD; EPIDEMIOLOGY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; UGANDA; VIROLOGY;

ADOLESCENT; ADULT; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; UGANDA;

EID: 0034340473     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Corey L. and Spear P.G. Infections with herpes simplex viruses. N. Engl. J Med. 1986; 314:749-759.
2. Hook E.W. III, Cannon R.O. and Nahmias A.J., et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J. Infect. Dis. 1992; 165:251-5.
3. Holmberg S.D., Stewart J. and Gerber R., et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. J. Amer. Med. Assoc. 1988; 259:1048-1050.
4. Wagner H.U., Van Dyck E. and Roggen E. et al. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int. J. STD-AIDS. 1994; 5:332-337.
5. Nahmias A.J., Lee F.K. and Beckman-Nahmias S. Seroepidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J. Infect. Dis. Suppl. 1990; 69:19-36.
6. Norrild B. Immunocytochemistry of herpes simplex virus glycoproteins. Curr. Top. Microb. Immunol. 1980; 90:68-106.
7. Nahmias A.J., Lee F.K. and Pereira L. et al. Monoclonal antibody immunoafinity purified glycoproteins for the detection of herpes simplex virus type 1 and type 2 specific antibodies in serum. In. Lopez C and Roizman B ed. Human herpes infections. Raven press. New York. -1986; 203-210.
8. Ackerman M., Longnecker R. and Roizman B., et al. Identification, properties and gene location of a novel glycoprotein specified by herpes simplex virus type 1. Virology 1986; 150:207-220.
9. Marsden H.S., Stow N. and Preston V, et al. Physical mapping of herpes simplex virus induced polypeptides. J. Virol. 1978;28:624-642.
10. Wawer M.J., Gray R.H. and Sewankambo N.K. et al. A randomised community-based trial of intense sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS. 1998; 12: 1211-1225.
11. Wawer M.J., Sewankambo N.K. and Serwadda D. et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Lancet 1999; 353:525-535.
12. Langeland N., Haar L. and Mhalu F. Prevalence of HSV-2 antibodies among STD clinic patients in Tanzania. Int. J. STD-AIDS 1988; 9:104-107.
13. Sanchez J., Gotuzzo E. and Escamilla J. et al. Gender differences in sexual practices and sexually transmitted infections among adults in Lima, Peru. Amer. J. Publ. Hlth. 1996; 86:1098-1107.
14. Boulus R., Ruff A.J. and Nahmias A. et al. Herpes simplex virus type 2 infection, syphilis, and hepatitis B virus infection in Haitian women with Human immunodeficiency virus type 1 and Human T-Lymphotropic virus type 1 infections. J. Infect. Dis. 1992; 166:418-420.
15. Catotti D.N., Clarke P. and Catoe K.E. Herpes revisited. Still a cause of concern. Sex Tran. Dis. 1993; 20:77-80.
16. Chenitz W.C. and Swanson M. Counselling clients with genital herpes. J Psychosocial Nursing 1989; 27:11-17.